|
QRSL1 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.987680E-04 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
8.572900E-04 |
| Normal-vs-Stage2 |
3.875800E-02 |
| Normal-vs-Stage3 |
3.358100E-02 |
| Normal-vs-Stage4 |
9.315800E-01 |
| Stage1-vs-Stage2 |
9.269000E-01 |
| Stage1-vs-Stage3 |
9.404200E-01 |
| Stage1-vs-Stage4 |
2.132600E-01 |
| Stage2-vs-Stage3 |
8.863000E-01 |
| Stage2-vs-Stage4 |
2.518200E-01 |
| Stage3-vs-Stage4 |
2.466200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.94910000000026E-05 |
| Normal-vs-AfricanAmerican |
3.287400E-01 |
| Normal-vs-Asian |
3.775800E-01 |
| Caucasian-vs-AfricanAmerican |
4.674100E-02 |
| Caucasian-vs-Asian |
8.886000E-01 |
| AfricanAmerican-vs-Asian |
5.828800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.029290E-04 |
| Normal-vs-Female |
2.451500E-02 |
| Male-vs-Female |
2.748600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
2.562700E-03 |
| Normal-vs-Extreme_Weight |
5.00300000316756E-08 |
| Normal-vs-Obese |
2.064400E-01 |
| Normal-vs-Extreme_Obese |
7.476000E-01 |
| Normal_Weight-vs-Extreme_Weight |
1.445230E-01 |
| Normal_Weight-vs-Obese |
1.039560E-01 |
| Normal_Weight-vs-Extreme_Obese |
2.531400E-01 |
| Extreme_Weight-vs-Obese |
6.965400E-04 |
| Extreme_Weight-vs-Extreme_Obese |
1.393760E-01 |
| Obese-vs-Extreme_Obese |
5.139400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.119400E-01 |
| Normal-vs-Age(41-60Yrs) |
4.589500E-02 |
| Normal-vs-Age(61-80Yrs) |
5.94979999999357E-05 |
| Normal-vs-Age(81-100Yrs) |
7.1132000001306E-07 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.480200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.775400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.790490E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.155500E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.283500E-03 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.900000E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
3.639600E-04 |
| Normal-VS-Type2 PRCC |
4.836200E-03 |
| Normal-VS-KIRP CIMP |
3.327400E-01 |
| Normal-VS-Unclassified PRCC |
3.420000E-02 |
| Type1 PRCC-VS-Type2 PRCC |
8.215400E-01 |
| Type1 PRCC-VS-KIRP CIMP |
6.042600E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
8.175000E-01 |
| Type2 PRCC-VS-KIRP CIMP |
6.321600E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
9.467000E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
6.375200E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
6.43630000000117E-05 |
| Normal-vs-N1 |
4.735200E-01 |
| Normal-vs-N2 |
1.85193999999722E-05 |
| N0-vs-N1 |
2.167900E-02 |
| N0-vs-N2 |
9.662400E-02 |
| N1-vs-N2 |
8.517800E-03 |
|
|
